Trial Details

NOT_YET_RECRUITING
Basic Information
Clinical ID c918
Identifier NCT06614387
Trial Title Vedolizumab in Pediatric Ulcerative Colitis- Comparison With Infliximab
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: Infliximab
Participant Information
Sponsor JAROSLAW KIERKUS
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2024-10-01
Primary Completion Date 2028-04-30
Completion Date 2028-11-30